Procured Health, a leading developer of web- based solutions that drive efficiency and savings in the hospital supply chain, has announced a $4.0M Series A Investment Round led by FCA Venture Partners.
Read MoreNASHVILLE, TENN. (March 5, 2014) - FCA Venture Partners (“FCA”), a leading source of equity capital for early-stage companies in the Southeast and venture capital manager of Clayton Associates, announces the completion of its advisory board with the additions of Paul Rutledge, Herb Fritch, George Salem, Larry McTavish, and Leon Drennan. They join Larry Kloess, former President of HCA TriStar, Jim Fitzgerald, founder and former President of Health Trust Purchasing Group, John Ingram, CEO of Ingram Content Group, Aubrey Harwell, managing partner of Neal & Harwell, PLC, Stuart McWhorter, Partner and Chairman of Clayton Associates, and Clayton McWhorter, Founder and Chairman Emeritus of Clayton Associates.
Read MoreFCA Venture Partners, the venture capital manager of investment firm Clayton Associates, announced today that Andrew Bouldin has been promoted to Principal.
Andrew joined FCA in 2010 as an associate. His work is primarily focused on FCA’s most recent fund, FCA V, a $53M fund investing in the healthcare services and information technologies industries, targeting early to growth stage businesses led by strong management teams with capital efficient, scalable, and disruptive business models.
Read MoreLast November, Clayton Associates hosted a CEO Forum with the management teams of all of its healthcare related portfolio companies.
The featured guest were Bill Carpenter, CEO of LifePoint Hospitals, and Bill Rutherford, CFO of Hospital Corporation of America.
Read MoreClinical Ink, the pioneering provider of eSource solutions for clinical trials, has announced a $4.3M Series B Investment Round led by FCA Venture Partners. “This infusion of funds will allow Clinical Ink to aggressively build the capabilities needed to address the rapidly increasing customer demand for eSource technology in clinical trials,” said Ed Seguine, CEO of Clinical Ink. “Our business has more than doubled in the last year and we will be expanding our management team, development capabilities, and implementation resources to support a wider range of clinical trials globally. Our customers, from large pharma to small biotech, have achieved real productivity gains at a fraction of the cost of current solutions and we will be in a position to continue to support innovative approaches to remote monitoring, site selection, and data management.”
Read MoreCatavolt, Inc., creator of the world's first cloud middleware enterprise mobility platform, today announced the close of a $5M Series B investment round. San Francisco-based, Toba Capital, recently formed by Vinny Smith, former CEO and Founder of Quest Software, led the round in cooperation with Nashville, Tennessee-based FCA Venture Partners, an existing investor in Catavolt and Series A participant. The capital received from this round will be used to expand the sales organization, market the company's cloud middleware platform more aggressively, and further expand the product innovation team.
Read MoreFCA Venture Partners (“FCA”), the venture capital manager of investment firm Clayton Associates, announced the closing of its fifth fund, FCA Venture Partners V, L.P. (“FCA V” or the “Fund”), which exceeded its target with total commitments of $53 million.
FCA V is led by partners Matthew King and John Burch, along with CFO and partner Nancy Allen, who have more than 70 years combined operational and investment experience.
“We are very pleased with the continued support from our existing investors, many of whom have recommitted following investments in previous funds, which, along with a large number of new investors to the Fund, has dramatically increased our investor base,” said John Burch, Partner of FCA Venture Partners. FCA V’s Limited Partners include regional banks, leading asset management firms, family offices, entrepreneurs, and high net worth individuals.
Read MoreCatavolt, Inc., a recognized market innovator in enterprise mobility, today announced it has closed a $1.5 million Series A investment round led by FCA Venture Partners, a Nashville, TN based venture capital firm, with participation by angel investor George Salem. Catavolt’s primary service offering is Catavolt Extender, a hybrid cloud service that securely provides real time mobile access to all enterprise data in the form of native applications to any mobile device.
Catavolt’s unique approach, based on its patent-pending Dual Model Architecture, enables organizations to rapidly create and deliver mobile applications to business users without the need for costly and traditionally resource-intensive software development projects. Catavolt serves a wide variety of customers, from manufacturing and distribution, to the defense industry and healthcare, which are competitively providing access to enterprise data for their business users on their own mobile devices.
Read More